Jamie L. Reynoso

CIK 1839066 · CEO, Medicare Advantage · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.48M

Companies

2

Total Filings

62

Lifetime Open-Market Net

-$385.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLOV CEO, Medicare Advantage 2,849,921 $4.73 $13.48M -$385.6K 60 2026-06-11
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOVW) Delisted Chief Operating Officer 220,820 $2.02 $446.1K $0 2 2021-07-20

Recent Filings · Page 2 of 7

62 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-12-16 CLOV Tax (F) −21,258 -$57.4K EDGAR
2025-11-05 CLOV Sell (S) −30,385 -$108.8K EDGAR
2025-11-04 CLOV Tax (F) −131,430 -$463.9K EDGAR
2025-10-21 CLOV Sell (S) −16,514 -$44.4K EDGAR
2025-10-17 CLOV Tax (F) −71,432 -$200.0K EDGAR
2025-10-07 CLOV Mixed −10,718 -$27.9K EDGAR
2025-09-19 CLOV Sell (S) −4,914 -$15.2K EDGAR
2025-09-16 CLOV Tax (F) −21,258 -$65.7K EDGAR
2025-09-16 CLOV Grant (A) +518,000 $0 EDGAR
2025-09-16 CLOV Tax (F) −85,596 -$238.8K EDGAR
Showing 1120 of 62
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.